Product NDC: | 0069-1441 |
Proprietary Name: | Ondansetron |
Non Proprietary Name: | Ondansetron |
Active Ingredient(s): | 2 mg/mL & nbsp; Ondansetron |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0069-1441 |
Labeler Name: | Pfizer Laboratories Div Pfizer Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA079224 |
Marketing Category: | ANDA |
Start Marketing Date: | 20130504 |
Package NDC: | 0069-1441-40 |
Package Description: | 1 VIAL, MULTI-DOSE in 1 CARTON (0069-1441-40) > 20 mL in 1 VIAL, MULTI-DOSE |
NDC Code | 0069-1441-40 |
Proprietary Name | Ondansetron |
Package Description | 1 VIAL, MULTI-DOSE in 1 CARTON (0069-1441-40) > 20 mL in 1 VIAL, MULTI-DOSE |
Product NDC | 0069-1441 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Ondansetron |
Dosage Form Name | INJECTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 20130504 |
Marketing Category Name | ANDA |
Labeler Name | Pfizer Laboratories Div Pfizer Inc |
Substance Name | ONDANSETRON HYDROCHLORIDE |
Strength Number | 2 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Serotonin 3 Receptor Antagonists [MoA],Serotonin-3 Receptor Antagonist [EPC] |